Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Brain (and spinal cord) tumours
Closed
Phase 1
This study is looking at a targeted treatment called 123I-ATT001 for a type of brain tumour called that has come back after treatment.
Recruitment start: 4 July 2024
Recruitment end: 27 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Mulholland
Theragnostics Limited, an Ariceum company
Last reviewed: 03 Mar 2026
CRUK internal database number: 19962